Evidence map›Paper›PMID 39584688›Full record

ArticleJournal of visualized experiments : JoVE2024

Fentanyl Analog Screening using LC-TIMS-TOF MS/MS.

Andrew R Forero, Lilian Valadares Tose, Matthew Willetts, Melvin A Park, Elisa N Shoff, Francisco Fernandez-Lima

Abstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Interpol review of forensic drug chemistry, 2022-2025.Forensic science international. Synergy · 2026
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Andrew R ForeroDepartment of Chemistry and Biochemistry, Florida International University.
Lilian Valadares ToseDepartment of Chemistry and Biochemistry, Florida International University.
Matthew WillettsBruker Daltonics Inc.
Melvin A ParkBruker Daltonics Inc.
Elisa N ShoffMiami-Dade County Medical Examiner Department.
Francisco Fernandez-LimaDepartment of Chemistry and Biochemistry, Florida International University; Biomolecular Sciences Institute, Florida International University; fernandf@fiu.edu.

Funding

Development of Multidimensional, Linear and Differential Ion Mobility MS Separations for Middle-Down ProteoformsR01GM134247 · NIGMS · FLORIDA INTERNATIONAL UNIVERSITY · PI FERNANDEZ-LIMA, FRANCISCO · 2019 to 2022
$1.7M
Development of biological structural tools for the study of protein-DNA complexesR35GM153450 · NIGMS · FLORIDA INTERNATIONAL UNIVERSITY · PI Francisco Fernandez-Lima · 2024 to 2026
$1.2M
NIGMS NIH HHS R01 GM134247NIGMS NIH HHS R35 GM153450
6 · The paper itself

Abstract

The use of fentanyl and the emergence of fentanyl analogs over recent decades has become an increasing concern to the community at large. Fentanyl and its analogs are the major contributors to fatal and nonfatal overdoses in the United States. Most recent cases of fentanyl-related overdose are linked to illicitly manufactured fentanyl and its associated extreme potency. In the present work, we describe a high-throughput analytical protocol for the screening of fentanyl analogs. The use of complementary liquid chromatography, trapped ion mobility spectrometry, and tandem mass spectrometry allow for the separation and assignment of hundreds of fentanyl analogs from a single sample in a single scan. The described approach takes advantage of the recent development of data-dependent acquisition and data-independent acquisition using parallel accumulation in the mobility trap followed by sequential fragmentation using collision-induced dissociation. The fentanyl analogs are confidently assigned based on their retention time, mobility, and MS fragmentation pattern.

Indexed as

FentanylTandem Mass SpectrometryAnalgesics, OpioidChromatography, LiquidHumansIon Mobility SpectrometryAnalgesics, OpioidFentanyl

Identifiers

PMID39584688
PMCPMC11771954

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.